Status:
RECRUITING
Low-dose Tolvaptan for Inpatient Hyponatraemia.
Lead Sponsor:
King's College Hospital NHS Trust
Conditions:
Hyponatremia
SIADH
Eligibility:
All Genders
18-90 years
Brief Summary
This is a retrospective cohort study to assess the safety and efficacy of low first dose of Tolvaptan and low or standard second dose of Tolvaptan in patients with moderate to severe hyponatraemia ass...
Eligibility Criteria
Inclusion
- All patients presenting to Accident \& Emergency department or seen as inpatients with moderate to severe hyponatraemia (sNa: \<125mmol) associated with SIADH and not responding to conservative measures of hyponatraemia management.
- Patients of all genders aged 18-90 y.o
Exclusion
- Pregnant women and patients aged \< 18y.o
- Hyponatraemia not associated with SIADH
Key Trial Info
Start Date :
March 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT06171100
Start Date
March 15 2024
End Date
December 30 2024
Last Update
March 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King's College Hospital NHS Foundation Trust
London, United Kingdom